
24 Feb 2020
PCR @ ACC 2020 Scientific Sessions
The Interventional Cardiology perspective!
Live updates on a selection of major Late Breaking Clinical Trials of interest in interventional cardiology presented at the American College of Cardiology 2020 Scientific Sessions #ACC20.
Late-breaking Trials
View the full American College of Cardiology 2020 Scientific Sessions Programme.
- POPular TAVI Trial - Cohort B: Antithrombotic Therapy After Transcatheter Aortic Valve Implantation In Patients With A Long-term Indication For Oral Anticoagulation
- The United Kingdom Transcatheter Aortic Valve Implantation (UK TAVI) Trial
- The Partner 3 Low-risk Randomized Trial: Two-year Clinical And Echocardiographic Outcomes
- Primary Results From The Spyral Htn-off Med Pivotal Trial: Catheter-based Renal Denervation In The Absence Of Antihypertensive Medications
- Relationships Of Ischemia Severity And Coronary Artery Disease Extent With Clinical Outcomes In The Ischemia Trial
- Ticagrelor With Or Without Aspirin In Acute Coronary Syndrome After Percutaneous Coronary Intervention: Randomized Evaluation Of Ticagrelor Monotherapy After 3-month Dual-antiplatelet Therapy In Acute Coronary Syndrome
- Ten-year Outcomes After Drug-eluting Stents Versus Coronary Artery Bypass Grafting For Left Main Coronary Disease
Read these reports by Mirvat Alasnag (King Fahd Armed Forces Hospital - Jeddah, Saudi Arabia) and Luis Ortega-Paz (Clinical and Provincial Hospital of Barcelona - Spain).